JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients

Thumbnail Image
Files
JAK-STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients.pdf(2.27 KB)
Date
2020
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
URI
https://doi.org/10.1159/000510179
 https://repositorio.uc.cl/handle/11534/62548
Collections
Artículos de revistas